Are You or Someone You Love Experiencing Memory Loss?
Researchers at Mass General Brigham are looking for volunteers ages 65-85 with mild cognitive impairment to explore the effects of a non-invasive experimental treatment. Join our compensated study today!
Compensation Provided
Have a Study Partner Who Can Provide Information
65-85 Years Old
Diagnosed with Mild Cognitive Impairment or Early Alzheimer's
Fast Facts
About Our Research Study
The purpose of this research study is to evaluate the effects of a non-invasive experimental treatment for mild cognitive impairment and memory loss. People with mild cognitive impairment (MCI) have a slight but noticeable decline in cognitive function (memory and thinking skills) that is worse than expected for their age, but not severe enough to interfere with their daily activities. Research suggests that some individuals living with MCI may go on to develop dementia. However, not everyone does. Researchers at Mass General Brigham are exploring the effects of an experimental therapy called Transcranial Photobiomodulation (tPBM) in adults with MCI. tPBM is a non-invasive treatment that delivers near-infrared light through a helmet-like device to stimulate blow flow to certain parts of the brain. Blood flow stimulation may improve symptoms of MCI. Your participation in this study may help researchers develop better treatments for MCI and early Alzheimer's disease. If you or a loved one are struggling with memory loss, join our study today! |
Additional Information
The purpose of this study is to evaluate the effects of Transcranial Photobiomodulation (tPBM) on adults with mild cognitive impairment (MCI). tPBM uses a form of near-infrared light that's invisible to the human eye to stimulate blood flow to the brain. Researchers want to know if tPBM can improve symptoms of MCI.
You may qualify for this study if you meet the following criteria.
Inclusion Criteria:
Inclusion Criteria:
- 65-85 years old
- Experiencing memory loss or mild cognitive impairment
- Have a study partner who can help provide medical information
Participation in this study involves:
- Completing online and in-person screenings
- Cognitive testing, a physical exam, and PET and fMRI scans (optional)
- 24 treatment visits lasting about one hour taking place 3 times a week over the course of 8 weeks
- Virtual and in person follow up visits one week, two weeks and eight weeks after the treatment phase of the study
Eligible participants will receive up to $1550 for completing this study.
There is no cost for you to participate in this study.